We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy
Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation
Following the worldwide COVID-19 outbreak, the pharmaceutical industry faces both potential and increased complications. In the near future, there are a few important things for pharma to keep an eye
Read ArticleYears of preclinical and clinical trials on mRNA vaccines for cancer therapy have laid the groundwork for making mRNA vaccines during the COVID-19 pandemic. The inherent benefit of ease of production,
Researchers claim to have made progress in developing a vaccine that will protect against all 20 forms of influenza. The effective Covid vaccines employ the same messenger-ribonucleic acid (mRNA) tech
Subscribe to our weekly pharmaceutical intelligence digest